|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.74 USD | +0.57% |
|
-12.93% | +12.21% |
| 07-01 | Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating | MT |
| 06-29 | Septerna, Inc.(NasdaqGM:SEPN) added to Russell 2000 Growth Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.42B | - | - | |||
| 49.7B | |||||
| 38.09B | - | - | - | - | - |
| 35.29B | |||||
| 35.13B | |||||
| 27.22B |
- Stock Market
- Stocks
- SEPN Stock
- Charts Septerna, Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
